NFIB and small cell lung carcinoma: Together, the identification of the transcription factor NFIB in mouse models and its validation in human tumors indicates that acquiring high levels of NFIB by gene amplification and/or other mechanisms contribute to the acquisition of metastatic ability by SCLC.